Follow Us On Social Media

 
 
READ ARTICLE

FDA Accepts NDA Filing for MT Pharma’s Investigational ALS Treatment

The FDA accepted the Mitsubishi Tanabe Pharma’s New Drug Application (NDA) for edaravone (MCI-186), an intravenous treatment for amyotrophic lateral sclerosis (ALS). Edaravone is described as a free radical scavenger that is believed to relieve the effects of oxidative stress, a likely factor …

READ ARTICLE

Inhaled Levodopa Impresses in Treating Parkinson’s OFF Periods in Phase 3 Study

READ ARTICLE

New Corticosteroid Approved for Duchenne Muscular Dystrophy

READ ARTICLE

Blood Biomarker for Quick and Accurate Prognosis of MS Identified

READ ARTICLE

Burnout Affects 60 Percent of US Neurologists

Contact Info

For advertising rates and opportunities:
Steve Farrell
Publisher
973-768-8681
sfarrell@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC